Myeloid-derived suppressor cells in parasitic infections

European Journal of Immunology

Volumn 40, Issue 11, 2010, Pages 2976-2985

  Van Ginderachter, Jo A ^a,b   Beschin, Alain ^a,b   Baetselier, Patrick De ^a,b   Raes, Geert ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Myeloid derived suppressor cells; Myelopoiesis; Parasitic infection; T cell suppression

Indexed keywords

CALGRANULIN B; CD11B ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE;

AFRICAN TRYPANOSOMIASIS; BRUGIAN FILARIASIS; CELL EXPANSION; CHAGAS DISEASE; COLONY FORMING UNIT GM; CYTOKINE RELEASE; HUMAN; IMMUNOMODULATION; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MYELOID DERIVED SUPPRESSOR CELL; MYELOPOIESIS; NONHUMAN; PARASITE VIRULENCE; PARASITOSIS; PHENOTYPE; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS MANSONI; SUPPRESSOR CELL; TAENIASIS; TH1 CELL; TH2 CELL; TOXOPLASMOSIS; ANIMAL; BONE MARROW CELL; EXTRAMEDULLARY HEMATOPOIESIS; HELMINTHIASIS; HOST PARASITE INTERACTION; IMMUNOLOGY; PARASITOLOGY; PROTOZOAL INFECTION;

ANIMALS; HELMINTHIASIS; HEMATOPOIESIS, EXTRAMEDULLARY; HOST-PARASITE INTERACTIONS; HUMANS; MYELOID CELLS; MYELOPOIESIS; PROTOZOAN INFECTIONS;

EID: 79952113538     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040911     Document Type: Review

References (88)

1. Noël, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P. and Beschin, A., Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004. 20: 126-133.
2. Raes, G., Beschin, A., Ghassabeh, G. H. and De Baetselier, P., Alternatively activated macrophages in protozoan infections. Curr. Opin. Immunol. 2007. 19: 454-459.
3. Kreider, T., Anthony, R. M., Urban, J. F., Jr. and Gause, W. C., Alternatively activated macrophages in helminth infections. Curr. Opin. Immunol. 2007. 19: 448-453.
4. Gabrilovich, D. I., Bronte, V., Chen, S. H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S. and Schreiber, H., The terminology issue for myeloid-derived suppressor cells. Cancer Res. 2007. 67: 425; author reply 426.
5. Fleming, T. J., Fleming, M. L. and Malek, T. R., Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 1993. 151: 2399-2408.
6. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. and Van Ginderachter, J. A., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
7. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
8. Van Ginderachter, J. A., Meerschaut, S., Liu, Y., Brys, L., De Groeve, K., Hassanzadeh Ghassabeh, G., Raes, G. and De Baetselier, P., Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 2006. 108: 525-535.
9. Greifenberg, V., Ribechini, E., Rossner, S. and Lutz, M. B., Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 2009. 39: 2865-2876.
10. Dietlin, T. A., Hofman, F. M., Lund, B. T., Gilmore, W., Stohlman, S. A. and van der Veen, R. C., Mycobacteria-induced Gr-1+subsets from distinct myeloid lineages have opposite effects on T cell expansion. J. Leukoc. Biol. 2007. 81: 1205-1212.
11. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M. et al., Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010. 40: 22-35.
12. Geissmann, F., Jung, S. and Littman, D. R., Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003. 19: 71-82.
13. Sunderkotter, C., Nikolic, T., Dillon, M. J., Van Rooijen, N., Stehling, M., Drevets, D. A. and Leenen, P. J., Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004. 172: 4410-4417.
14. Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A. and Pamer, E. G., TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003. 19: 59-70.
15. Guilliams, M., Movahedi, K., Bosschaerts, T., VandenDriessche, T., Chuah, M. K., Herin, M., Acosta-Sanchez, A. et al., IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J. Immunol. 2009. 182: 1107-1118.
16. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Basso, G. et al., Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+T cells. J. Clin. Invest. 2006. 116: 2777-2790.
17. Cotterell, S. E., Engwerda, C. R. and Kaye, P. M., Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha. Blood 2000. 95: 1642-1651.
18. Cotterell, S. E., Engwerda, C. R. and Kaye, P. M., Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect. Immun. 2000. 68: 1840-1848.
19. Lelchuk, R., Graveley, R. and Liew, F. Y., Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro. Cell. Immunol. 1988. 111: 66-76.
20. Mirkovich, A. M., Galelli, A., Allison, A. C. and Modabber, F. Z., Increased myelopoiesis during Leishmania major infection in mice: generation of 'safe targets', a possible way to evade the effector immune mechanism. Clin. Exp. Immunol. 1986. 64: 1-7.
21. Voronov, E., Dotan, S., Gayvoronsky, L., White, R. M., Cohen, I., Krelin, Y., Benchetrit, F. et al., IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice. Int. Immunol. 2010. 22: 245-257.
22. Goni, O., Alcaide, P. and Fresno, M., Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+)immature myeloid suppressor cells. Int. Immunol. 2002. 14: 1125-1134.
23. Sponaas, A. M., Freitas do Rosario, A. P., Voisine, C., Mastelic, B., Thompson, J., Koernig, S., Jarra, W. et al., Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood 2009. 114: 5522-5531.
24. Belyaev, N. N., Brown, D. E., Diaz, A. I., Rae, A., Jarra, W., Thompson, J., Langhorne, J. and Potocnik, A. J., Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria. Nat. Immunol. 2010. 11: 477-485.
25. Asami, M., Owhashi, M., Abe, T. and Nawa, Y., A comparative study of the kinetic changes of hemopoietic stem cells in mice infected with lethal and non-lethal malaria. Int. J. Parasitol. 1992. 22: 43-47.
26. Clark, C. R., Chen, B. D. and Boros, D. L., Macrophage progenitor cell and colony-stimulating factor production during granulomatous schistosomiasis mansoni in mice. Infect. Immun. 1988. 56: 2680-2685.
27. Khalil, R. M., Luz, A., Mailhammer, R., Moeller, J., Mohamed, A. A., Omran, S., Dormer, P. and Hultner, L., Schistosoma mansoni infection in mice augments the capacity for interleukin 3 (IL-3) and IL-9 production and concurrently enlarges progenitor pools for mast cells and granulocytes-macrophages. Infect. Immun. 1996. 64: 4960-4966.
28. Dutra, H. S., El-Cheikh, M. C., Azevedo, S. P., Rossi, M. I. and Borojevic, R., Murine schistosomiasis mansoni: experimental analysis of bone marrow and peripheral myelopoiesis. Parasitol. Res. 1998. 84: 668-675.
29. Dutra, H. S., Rossi, M. I., Azevedo, S. P., El-Cheikh, M. C. and Borojevic, R., Haematopoietic capacity of colony-forming cells mobilized in hepatic inflammatory reactions as compared to that of normal bone marrow cells. Res. Immunol. 1997. 148: 437-444.
30. Alvarez-Silva, M., da Silva, L. C. and Borojevic, R., Cell membrane-associated proteoglycans mediate extramedullar myeloid proliferation in granulomatous inflammatory reactions to schistosome eggs. J. Cell. Sci. 1993. 104: 477-484.
31. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S. et al., Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010. 32: 790-802.
32. Lechner, M. G., Liebertz, D. J. and Epstein, A. L., Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 2010. 185: 2273-2284.
33. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O'Malley, K. A. et al., MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 2007. 204: 1463-1474.
34. Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M. et al., Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 2008. 205: 2235-2249.
35. Titus, R. G., Sherry, B. and Cerami, A., The involvement of TNF, IL-1 and IL-6 in the immune response to protozoan parasites. Immunol. Today 1991. 12: A13-A16.
36. Drennan, M. B., Stijlemans, B., Van den Abbeele, J., Quesniaux, V. J., Barkhuizen, M., Brombacher, F., De Baetselier, P. et al., The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol. 2005. 175: 2501-2509.
37. Egan, C. E., Sukhumavasi, W., Butcher, B. A. and Denkers, E. Y., Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii. Clin. Exp. Immunol. 2009. 156: 17-24.
38. Ngure, R. M., Eckersall, P., Burke, J., Karori, S. M., Mwangi, W. W., Wachira, F. N., Maathai, R. and Murray, M., Endotoxin-like effects in acute phase response to Trypanosoma brucei brucei infection are not due to gastrointestinal leakage. Parasitol. Int. 2009. 58: 325-329.
39. Layland, L. E., Wagner, H. and da Costa, C. U., Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/-mice. Eur. J. Immunol. 2005. 35: 3248-3257.
40. Everts, B., Smits, H. H., Hokke, C. H. and Yazdanbakhsh, M., Helminths and dendritic cells: sensing and regulating via pattern recognition receptors, Th2 and Treg responses. Eur. J. Immunol. 2010. 40: 1525-1537.
41. Marshall, M. A., Jankovic, D., Maher, V. E., Sher, A. and Berzofsky, J. A., Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factor. Microbes Infect. 2001. 3: 1051-1061.
42. Giordanengo, L., Guinazu, N., Stempin, C., Fretes, R., Cerban, F. and Gea, S., Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 2002. 32: 1003-1011.
43. Sunderkotter, C., Kunz, M., Steinbrink, K., Meinardus-Hager, G., Goebeler, M., Bildau, H. and Sorg, C., Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 1993. 151: 4891-4901.
44. Steinbrink, K., Schonlau, F., Rescher, U., Henseleit, U., Vogel, T., Sorg, C. and Sunderkotter, C., Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells. Immunobiology 2000. 202: 442-459.
45. Yang, T. H., Tzeng, S., Cheng, I., Burnett, M. G., Yoshizawa, Y., Fukuyama, K., Lee, S. C. and Epstein, W. L., Identification of the mouse calcium-binding proteins, MRP 8 and MRP 14, in Schistosoma mansoni-induced granulomas: biochemical and functional characterization. J. Leukoc. Biol. 1997. 61: 258-266.
46. Goodridge, H.S., Marshall, F.A., Wilson, E.H., Houston, K.M., Liew, F.Y., Harnett, M. M. and Harnett, W., In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology 2004. 113: 491-498.
47. Kusmartsev, S. and Gabrilovich, D. I., STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 2005. 174: 4880-4891.
48. Voisin, M. B., Buzoni-Gatel, D., Bout, D. and Velge-Roussel, F., Both expansion of regulatory GR1+CD11b+myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect. Immun. 2004. 72: 5487-5492.
49. Dunay, I. R., Damatta, R. A., Fux, B., Presti, R., Greco, S., Colonna, M. and Sibley, L. D., Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008. 29: 306-317.
50. Robben, P. M., LaRegina, M., Kuziel, W. A. and Sibley, L. D., Recruitment of Gr-1+monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 2005. 201: 1761-1769.
51. Munder, M., Eichmann, K. and Modolell, M., Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 5347-5354.
52. Hassanzadeh Ghassabeh, G., De Baetselier, P., Brys, L., Noel, W., Van Ginderachter, J. A., Meerschaut, S., Beschin, A. et al., Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 2006. 108: 575-583.
53. Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999. 10: 137-142.
54. Gordon, S. and Martinez, F. O., Alternative activation of macrophages: mechanism and functions. Immunity 2010. 32: 593-604.
55. Liu, Y., Van Ginderachter, J. A., Brys, L., De Baetselier, P., Raes, G. and Geldhof, A. B., Nitric oxide-independent CTL suppression during tumor progression: association with arginase-producing (M2) myeloid cells. J. Immunol. 2003. 170: 5064-5074.
56. Brys, L., Beschin, A., Raes, G., Ghassabeh, G. H., Noel, W., Brandt, J., Brombacher, F. and De Baetselier, P., Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 2005. 174: 6095-6104.
57. Loke, P., MacDonald, A. S. and Allen, J. E., Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naive CD4(+) T cells. Eur. J. Immunol. 2000. 30: 1127-1135.
58. Allen, J. E. and MacDonald, A. S., Profound suppression of cellular proliferation mediated by the secretions of nematodes. Parasite Immunol. 1998. 20: 241-247.
59. Gomez-Garcia, L., Lopez-Marin, L. M., Saavedra, R., Reyes, J. L., Rodriguez-Sosa, M. and Terrazas, L. I., Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells. Parasite Immunol. 2005. 27: 395-405.
60. Atochina, O., Daly-Engel, T., Piskorska, D., McGuire, E. and Harn, D. A., A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism. J. Immunol. 2001. 167: 4293-4302.
61. Terrazas, L. I., Walsh, K. L., Piskorska, D., McGuire, E. and Harn, D. A., Jr., The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections. J. Immunol. 2001. 167: 5294-5303.
62. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
63. Beschin, A., Brys, L., Magez, S., Radwanska, M. and De Baetselier, P., Trypanosoma brucei infection elicits nitric oxide-dependent and nitric oxide-independent suppressive mechanisms. J. Leukoc. Biol. 1998. 63: 429-439.
64. Abrahamsohn, I. A. and Coffman, R. L., Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 1995. 155: 3955-3963.
65. Ahvazi, B. C., Jacobs, P. and Stevenson, M. M., Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J. Leukoc. Biol. 1995. 58: 23-31.
66. Candolfi, E., Hunter, C. A. and Remington, J. S., Mitogen-and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect. Immun. 1994. 62: 1995-2001.
67. Dai, W. J. and Gottstein, B., Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection. Immunology 1999. 97: 107-116.
68. Dondji, B., Bungiro, R. D., Harrison, L. M., Vermeire, J. J., Bifulco, C., McMahon-Pratt, D. and Cappello, M., Role for nitric oxide in hookworm-associated immune suppression. Infect. Immun. 2008. 76: 2560-2567.
69. Candolfi, E., Hunter, C. A. and Remington, J. S., Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 1995. 63: 751-756.
70. Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M. et al., IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 2003. 170: 270-278.
71. Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M. et al., Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004. 20: 623-635.
72. Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W. et al., Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009. 5: e1000371.
73. Modolell, M., Choi, B. S., Ryan, R. O., Hancock, M., Titus, R. G., Abebe, T., Hailu, A. et al., Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis. PLoS Negl. Trop. Dis. 2009. 3: e480.
74. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. and Sacks, D. L., CD4+CD25+regulatory T cells control Leishmania major persistence and immunity. Nature 2002. 420: 502-507.
75. Taylor, M. D., LeGoff, L., Harris, A., Malone, E., Allen, J. E. and Maizels, R. M., Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol. 2005. 174: 4924-4933.
76. Hesse, M., Piccirillo, C. A., Belkaid, Y., Prufer, J., Mentink-Kane, M., Leusink, M., Cheever, A. W. et al., The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 2004. 172: 3157-3166.
77. Hansen, D. S. and Schofield, L., Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog 2010. 6: e1000771.
78. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M. and Chen, S. H., Gr-1+CD115+immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006. 66: 1123-1131.
79. Serafini, P., Mgebroff, S., Noonan, K. and Borrello, I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008. 68: 5439-5449.
80. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten, T. F. and Korangy, F., A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+) CD25(+)Foxp3(+) T cells. Gastroenterology 2008. 135: 234-243.
81. Yang, Z., Zhang, B., Li, D., Lv, M., Huang, C., Shen, G. X. and Huang, B., Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS One 2010. 5: e8922.
82. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Muller, M., Blander, J. M. et al., Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 2010. 207: 1453-1464.
83. De Santo, C., Salio, M., Masri, S. H., Lee, L. Y., Dong, T., Speak, A. O., Porubsky, S. et al., Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 2008. 118: 4036-4048.
84. Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P. and Ostrand-Rosenberg, S., Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 2010. 70: 68-77.
85. Yoneda, J., Andou, A. and Takehana, K., Regulatory roles of amino acids in immune response. Curr. Rheumatol. Rev. 2009. 5: 252-258.
86. Wanasen, N. and Soong, L., L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol. Res. 2008. 41: 15-25.
87. Peluffo, G., Piacenza, L., Irigoin, F., Alvarez, M. N. and Radi, R., L-arginine metabolism during interaction of Trypanosoma cruzi with host cells. Trends Parasitol. 2004. 20: 363-369.
88. Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J. and Montero, A. J., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 2009. 58: 49-59.